HEAL is trading at $29.88, up +3.34%, as broad U.S. markets rally.

  • The S&P 500 is up 1.08% and Nasdaq Composite 1.56%; risk appetite improved after markets absorbed the September 16 Federal Reserve rate hike.
  • Treasury prices rallied and crude oil fell, easing immediate inflation concerns.
  • No clear HEAL-specific catalyst was identified; GSK-Chimagen oncology deal concerns involve GSK and Chimagen, not HEAL.